Porin deficiency or plasmid copy number increase mediated carbapenem-resistant Escherichia coli resistance evolution

Emerg Microbes Infect. 2024 Dec;13(1):2352432. doi: 10.1080/22221751.2024.2352432. Epub 2024 May 20.

Abstract

This study investigated resistance evolution mechanisms of conjugated plasmids and bacterial hosts under different concentrations of antibiotic pressure. Ancestral strain ECNX52 was constructed by introducing the blaNDM-5-carrying IncX3 plasmid into E. coli C600, and was subjected to laboratory evolution under different concentrations of meropenem pressure. Minimal inhibitory concentrations and conjugation frequency were determined. Fitness of these strains was assessed. Whole genome sequencing and transcriptional changes were performed. Ancestral host or plasmids were recombined with evolved hosts or plasmids to verify plasmid or host factors in resistance evolution. Role of the repA mutation on plasmid copy number was determined. Two out of the four clones (EM2N1 and EM2N3) exhibited four-fold increase in MIC when exposed to a continuous pressure of 2 μg/mL MEM (1/32 MIC), by down regulating expression of outer membrane protein ompF. Besides, all four clones displayed four-fold increase in MIC and higher conjugation frequency when subjected to a continuous pressure of 4 μg/mL MEM (1/16 MIC), attributing to increasing plasmid copy number generated by repA D140Y (GAT→TAT) mutation. Bacterial hosts and conjugative plasmids can undergo resistance evolution under certain concentrations of antimicrobial pressure by reducing the expression of outer membrane proteins or increasing plasmid copy numbers.

Keywords: Escherichia coli; carbapenem; incX3 plasmid; outer membrane protein; plasmid copy number.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Carbapenem-Resistant Enterobacteriaceae / drug effects
  • Carbapenem-Resistant Enterobacteriaceae / genetics
  • Carbapenems / pharmacology
  • Conjugation, Genetic
  • Escherichia coli Proteins* / genetics
  • Escherichia coli Proteins* / metabolism
  • Escherichia coli* / drug effects
  • Escherichia coli* / genetics
  • Evolution, Molecular
  • Gene Dosage
  • Meropenem / pharmacology
  • Microbial Sensitivity Tests*
  • Mutation
  • Plasmids* / genetics
  • Porins* / genetics
  • Porins* / metabolism
  • Whole Genome Sequencing
  • beta-Lactamases / genetics

Grants and funding

This study was funded by the National Natural Science Foundation of China [grant numbers 81772249, 81871703], Natural Science Foundation of Guangdong Province [grant numbers 2021A1515010423, 2023A1515010607], and Science and Technology Projects in Guangzhou [grant number 202103000026]. The funders did not participate in study design, data collection and interpretation, or the decision to submit the work for publication.